|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-10-29
|
|
pubmed:abstractText |
This report discusses the limitations of using the serum tumour marker CA 125 in the preoperative evaluation of a woman presenting with a pelvic mass. We present 2 cases of benign struma ovarii which were associated with elevated levels of CA 125.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0004-8666
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
216-7
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Limitations of CA125 in the preoperative evaluation of a pelvic mass: struma ovarii and ascites.
|
|
pubmed:affiliation |
King Edward Memorial Hospital for Women, Perth, Western Australia.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
